$LIFE

Ethos (LIFE) Q2 2026 Earnings Call Transcript

Ethos Technologies (LIFE) reported Q2 2026 revenue of $189.6 million, up 113% Y/Y, with direct revenue $116.5 million (+131%) and third-party revenue $73.1 million (+90%). Adjusted EBITDA was $35.2 million (19% margin). Net income was $19.5 million. Full-year 2026 guidance: revenue $727-$731 million and adjusted EBITDA $119-$123 million. Up to $100 million Class A repurchase authorized.

Original reporting
Published Aug 11, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 4:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ethos (LIFE) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$LIFEBullishMed
01

Why it matters

Traders can update models using the disclosed Q2 performance, raised FY2026 revenue and adjusted EBITDA guidance, and the Q3 outlook. The $100M Class A repurchase authorization adds a capital-return catalyst, while ARPU decline and margin mix-down highlight execution risk.

02

Market read

A guidance-raise earnings call transcript with concrete financial ranges and a buyback authorization, likely driving near-term repricing and model updates.

03

What to watch

Commission receivable growth (+51% YoY) and the $8M timing benefit from a carrier settlement could make cash flow and profitability look better in the quarter than underlying run-rate.

Relevance 9/10Novelty 8/10Timing: post-market Aug. 3, 2026, for Q2 results and FY2026/Q3 guidance

Background

Ethos Technologies is an insurtech platform focused on real-time underwriting and distribution via direct and third-party agent channels.

Company-level read

Ticker impact

$LIFEBullishMedium confidence
Context

Ethos reported Q2 2026 revenue of $189.6M (+113% YoY) and raised FY2026 revenue guidance to $727M-$731M.

Expected impact

Bias upward for the next few sessions, with volatility around margin mix and ARPU trend.

Evidence & confidence

The article discloses multiple fresh, decision-relevant datapoints: Q2 results, raised FY and Q3 guidance ranges, and a new repurchase authorization. However, it also highlights ARPU down 8% YoY and margin mix-down from third-party acceleration, which can temper the reaction.

Market effects

Reinforces the life-insurance insurtech narrative that distribution scale and underwriting automation can drive growth, potentially influencing read-across sentiment for digital insurers.

Primarily US-focused given the stated addressable market and life insurance purchase base.

Limited direct global impact; mostly relevant to US listed insurtech and digital distribution investors.

Counterpoint

The third-party channel acceleration may be structurally dilutive to ARPU and margins, so guidance strength could be partially mix-driven rather than durable unit economics.

Key entities

  • Ethos Technologies Inc.

    Reported Q2 2026 results, raised FY2026 guidance, and authorized up to $100M of Class A share repurchases.

  • Peter Colis

    CEO who emphasized underwriting platform scaling velocity and potential AI-driven distribution tailwinds.

  • Chris Capozzi

    CFO who attributed margin profile changes to business mix, especially third-party growth acceleration.

Related articles

$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

$LIFEHigh

Ethos Technologies Inc. (LIFE): Results of Operations and Financial Condition

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 life-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Ethos Reports Second Quarter Fiscal Year 2026 Financial Results • Q2 Revenue grew 113% year-over-year to $190 million • Q2 Direct Channel Revenue grew 131% year-over-year to $116 million • Q2 Third-Party Revenue grew 90% year

$HALOHighAI 9/10

Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know

Halozyme Therapeutics (NASDAQ:HALO) shares rose about 18% after the company reported Q2 adjusted EPS of $2.28 on revenue of $481 million, beating consensus of $1.82 and $404.3 million. Halozyme cited 47.7% YoY revenue growth from ENHANZE royalties and milestones. It raised full-year guidance to $1.87B revenue and $8.83 adjusted EPS midpoint.

$FIVNHighAI 9/10

Five9 (FIVN) Stock Trades Up, Here Is Why

Five9 (NASDAQ:FIVN) shares rose about 18% after the company reported Q2 results above Wall Street expectations. Adjusted EPS was $0.70 on revenue of $312.4 million, with revenue up 10.3% year over year. Five9 raised full-year revenue guidance to $1.27 billion at the midpoint and forecast next-quarter sales above consensus.